The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years
Titel:
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years
Auteur:
Piazza, Rocco G. Magistroni, Vera Franceschino, Anna Andreoni, Federica Tornaghi, Lucia Colnaghi, Federica Corneo, Gianmarco Pogliani, Enrico M. Gambacorti-Passerini, Carlo